Viridian Therapeutics, Inc.\DE Quarterly Operating Income (Loss) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q3 2024.
  • Viridian Therapeutics, Inc.\DE Operating Income (Loss) for the quarter ending September 30, 2024 was -$83.5M, a 63% decline year-over-year.
  • Viridian Therapeutics, Inc.\DE Operating Income (Loss) for the twelve months ending September 30, 2024 was -$283M, a 22% decline year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Operating Income (Loss) for 2023 was -$254M, a 89.5% decline from 2022.
  • Viridian Therapeutics, Inc.\DE annual Operating Income (Loss) for 2022 was -$134M, a 68.5% decline from 2021.
  • Viridian Therapeutics, Inc.\DE annual Operating Income (Loss) for 2021 was -$79.7M, a 27.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$283M -$83.5M -$32.3M -63% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$251M -$72.2M -$12.9M -21.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$238M -$55.9M +$16.6M +22.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$254M -$71.5M -$22.4M -45.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$232M -$51.2M -$21.4M -72% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$211M -$59.3M -$29.7M -100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$181M -$72.5M -$46.6M -180% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$134M -$49.1M -$20M -68.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$114M -$29.8M -$15.7M -111% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$98.7M -$29.6M -$11.6M -64.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$87.1M -$25.9M -$7.37M -39.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$79.7M -$29.1M +$61.5M +67.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$141M -$14.1M -$8.72M -161% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$133M -$18M -$11.6M -182% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$121M -$18.5M -$10.5M -131% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$110M -$90.6M -$80.5M -800% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$29.9M -$5.41M +$5.82M +51.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$35.7M -$6.37M +$2.57M +28.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$38.2M -$8M +$3.74M +31.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$42M -$10.1M +$382K +3.65% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$42.4M -$11.2M -$2.08M -22.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$40.3M -$8.94M -$81K -0.91% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$40.2M -$11.7M -$7.12M -154% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$33.1M -$10.5M -$4.1M -64.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$29M -$9.15M -$3.26M -55.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$25.7M -$8.86M -$1.51M -20.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$24.2M -$4.62M +$2.32M +33.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$26.5M -$6.35M -$440K -7.44% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$26.1M -$5.89M -$1.81M -44.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$24.3M -$7.35M -$3.9M -113% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$20.4M -$6.94M -$3.4M -96% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$17M -$5.91M -$2.96M -100% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$14M -$4.08M -$954K -30.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$13.1M -$3.45M -$960K -38.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$12.1M -$3.54M -$929K -35.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$11.2M -$2.96M -$701K -31.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 -$10.5M -$3.13M -$1.5M -91.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-26
Q2 2015 -$8.99M -$2.49M +$321K +11.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$9.31M -$2.61M -$2.45M -1464% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$6.87M -$2.26M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-21
Q3 2014 -$1.63M -$1.32M -424% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$2.81M -$2.75M -4556% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$167K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 -$312K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$60.4K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.